Terms ending in 2035
Every in-force patent on Natera, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,486,008 | Detecting Mutations and Ploidy in Chromosomal Segments In force · Low confidence | Natera, Inc. | In force | Low confidence | |
| US 11,530,454 | Detecting Mutations and Ploidy in Chromosomal Segments In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 12,203,142 | Detecting Mutations and Ploidy in Chromosomal Segments In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 12,486,542 | Detecting Mutations and Ploidy in Chromosomal Segments In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 12,553,083 | Methods for Enriching and Sequencing Nucleic Acids for Non- Invasive Cancer Testing In force · High confidence | Natera, Inc. | In force | High confidence | |
| US 10,577,655 | Cell Free DNA Diagnostic Testing Standards In force · High confidence | Natera, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.